LAB Research Inc.'s Hungarian Site Successfully Completes GLP Certificate Inspection - Site Also Subject to Favourable FDA Audit
10/23/2008 4:37:20 PM
LAVAL, QC, Oct. 23 /CNW Telbec/ - LAB Research Inc. ("LRI" or "LAB
Research") (TSX: LRI), a Canadian-based global non-clinical contract research
organization ("CRO"), announced that its Hungarian site ("LAB Hungary")
successfully completed its biennial Good Laboratory Practices ("GLP")
inspection by the Hungarian authorities (OGYI: National Institute of Pharmacy)
(the "Inspection"). Consequently, its GLP certificate remains in full force.
In addition, to the Inspection, the site was also subject to a favourable
audit of the chronic inhalation studies performed for one of its sponsors (the
"Audit"), last August by the US Food and Drug Administration ("FDA"). The
Audit was conducted in conjunction with the OGYI and did not alter the GLP
status of the site.
comments powered by